FGEN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.98%

Insider Buying (Last 12 Months): $95,500.00

Insider Selling (Last 12 Months): $664,445.76

FibroGen Insider Trading History Chart

FibroGen Share Price & Price History

^$1.13

▼ -0.24 (-17.52%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

RSVP: Charles Payne’s Cash Flow Workshop

From Unstoppable Prosperity | Ad

Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.

FibroGen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/7/2024	Thane Wettig	CEO	Buy	50,000	$1.91	$95,500.00	470,178
9/1/2023	Jeffrey William Henderson	Director	Sell	2,000	$1.03	$2,060.00	28,866
8/4/2023	Jeffrey William Henderson	Director	Sell	2,000	$1.91	$3,820.00	30,866
7/11/2023	Jeffrey William Henderson	Director	Sell	2,000	$2.69	$5,380.00	32,866
7/7/2023	Enrique A Conterno	CEO	Sell	1,880	$2.80	$5,264.00	374,722
6/23/2023	Thane Wettig	Insider	Sell	791	$16.53	$13,075.23	108,261
6/13/2023	Christine Chung	SVP	Sell	6,250	$17.60	$110,000.00	242,577
6/9/2023	Benjamin Cravatt	Director	Sell	3,944	$17.17	$67,718.48	28,736
6/7/2023	Christine Chung	SVP	Sell	3,633	$17.04	$61,906.32	248,827
6/7/2023	Enrique A Conterno	CEO	Sell	8,897	$17.04	$151,604.88	376,602
6/7/2023	James A Schoeneck	Director	Sell	7,100	$18.03	$128,013.00	73,722
6/7/2023	Juan Graham	CFO	Sell	1,785	$16.99	$30,327.15	71,083
6/7/2023	Mark Eisner	EVP	Sell	2,042	$17.04	$34,795.68	162,862
6/7/2023	Thane Wettig	Insider	Sell	1,758	$17.04	$29,956.32	111,395
6/2/2023	Mark Eisner	EVP	Sell	1,090	$18.83	$20,524.70	164,904
4/10/2023	Enrique A Conterno	CEO	Sell	1,869	$19.52	$36,482.88	382,999
4/4/2023	Christine Chung	SVP	Sell	6,590	$18.78	$123,760.20	252,460
4/4/2023	Mark Eisner	Insider	Sell	9,182	$18.78	$172,437.96	165,994
3/23/2023	Thane Wettig	Insider	Sell	905	$18.71	$16,932.55	110,653
3/10/2023	Christine Chung	SVP	Sell	7,606	$20.20	$153,641.20	259,050
3/10/2023	Enrique A Conterno	CEO	Sell	31,589	$20.20	$638,097.80	384,868
3/10/2023	Juan Graham	CFO	Sell	4,912	$20.20	$99,222.40	72,868
3/10/2023	Mark Eisner	Insider	Sell	10,140	$20.20	$204,828.00	175,176
3/8/2023	Christine Chung	SVP	Sell	8,354	$21.16	$176,770.64	251,519
3/8/2023	Enrique A Conterno	CEO	Sell	24,672	$21.16	$522,059.52	356,111
3/8/2023	Juan Graham	CFO	Sell	2,749	$21.16	$58,168.84	70,213
3/8/2023	Mark Eisner	Insider	Sell	7,363	$21.16	$155,801.08	165,133
1/6/2023	Enrique A Conterno	CEO	Sell	1,538	$19.95	$30,683.10	295,483
12/23/2022	Thane Wettig	Insider	Sell	734	$15.80	$11,597.20	89,163
12/12/2022	Juan Graham	CFO	Sell	1,407	$14.50	$20,401.50	53,703
12/9/2022	Juan Graham	CFO	Sell	781	$14.90	$11,636.90	55,110
12/8/2022	Christine Chung	SVP	Sell	1,096	$15.79	$17,305.84	237,705
12/8/2022	Enrique A Conterno	CEO	Sell	2,543	$15.79	$40,153.97	297,020
12/8/2022	Thane Wettig	Insider	Sell	382	$15.79	$6,031.78	89,897
9/15/2021	Thomas F. Kearns, Jr.	Director	Sell	13,100	$11.58	$151,698.00
8/26/2021	Thane Wettig	Insider	Buy	3,100	$11.53	$35,743.00
6/15/2021	Pat Cotroneo	CFO	Sell	4,053	$25.62	$103,837.86	276,677

The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way

From Smallcaps Daily | Ad

See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.

Click to read

SEC Filings (Institutional Ownership Changes) for FibroGen (NASDAQ:FGEN)

72.71% of FibroGen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

FibroGen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2024	SG Americas Securities LLC	32,741	$77K	0.0%	-71.0%	0.033%
5/1/2024	BNP Paribas Financial Markets	139,053	$0.33M	0.0%	-47.2%	0.140%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	55,811	$0.13M	0.0%	N/A	0.056%
4/24/2024	Assenagon Asset Management S.A.	428,848	$1.01M	0.0%	-80.7%	0.434%
4/19/2024	Accel Wealth Management	43,955	$0.10M	0.0%	N/A	0.045%
2/14/2024	Pennant Investors LP	768,400	$0.68M	0.1%	N/A	0.781%
2/14/2024	Lighthouse Investment Partners LLC	153,764	$0.14M	0.0%	N/A	0.156%
2/13/2024	Armistice Capital LLC	9,764,000	$8.65M	0.1%	+23.7%	9.929%
2/9/2024	Primecap Management Co. CA	14,471,928	$12.83M	0.0%	-1.7%	14.716%
1/12/2024	SG Americas Securities LLC	112,783	$100K	0.0%	+79.8%	0.115%
12/19/2023	Public Employees Retirement System of Ohio	176,593	$0.15M	0.0%	+1,472.7%	0.180%
11/15/2023	Armistice Capital LLC	7,892,000	$6.81M	0.1%	+81.2%	8.025%
11/14/2023	Primecap Management Co. CA	14,724,968	$12.71M	0.0%	+7.7%	14.974%
11/13/2023	BHK Investment Advisors LLC	57,625	$50K	0.0%	-31.9%	0.059%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	109,453	$94K	0.0%	N/A	0.111%
11/13/2023	Algert Global LLC	161,550	$0.14M	0.0%	+488.4%	0.164%
11/13/2023	Acadian Asset Management LLC	1,615,094	$1.39M	0.0%	N/A	1.642%
11/7/2023	Quantbot Technologies LP	52,000	$45K	0.0%	N/A	0.053%
11/7/2023	New York State Common Retirement Fund	36,504	$31K	0.0%	-63.1%	0.037%
11/7/2023	Fox Run Management L.L.C.	42,720	$37K	0.0%	N/A	0.043%
11/6/2023	Assenagon Asset Management S.A.	2,226,857	$1.92M	0.0%	+49.7%	2.267%
10/25/2023	Mackenzie Financial Corp	51,490	$44K	0.0%	+112.6%	0.052%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	293,612	$0.25M	0.0%	+216.6%	0.299%
10/13/2023	SG Americas Securities LLC	62,710	$54K	0.0%	+498.8%	0.064%
8/14/2023	Prelude Capital Management LLC	16,933	$46K	0.0%	N/A	0.017%
8/14/2023	Graham Capital Management L.P.	11,668	$32K	0.0%	N/A	0.012%
8/11/2023	Nan Fung Group Holdings Ltd	62,106	$0.17M	0.1%	+82.1%	0.063%
8/11/2023	Natixis	79,900	$0.22M	0.0%	N/A	0.081%
8/11/2023	Vantage Consulting Group Inc	195,707	$0.53M	0.3%	-32.9%	0.199%
8/11/2023	Schroder Investment Management Group	3,356,570	$9.06M	0.0%	+123.0%	3.418%
8/10/2023	Profund Advisors LLC	66,254	$0.18M	0.0%	+42.9%	0.068%
8/3/2023	Mackenzie Financial Corp	24,215	$68K	0.0%	N/A	0.025%
8/2/2023	State of New Jersey Common Pension Fund D	138,888	$0.38M	0.0%	+31.2%	0.142%
8/2/2023	Sigma Planning Corp	46,950	$0.13M	0.0%	+88.3%	0.048%
7/25/2023	Assenagon Asset Management S.A.	1,487,691	$4.02M	0.0%	+10.6%	1.525%
7/24/2023	Allspring Global Investments Holdings LLC	11,378	$31K	0.0%	-81.0%	0.012%
7/19/2023	Daymark Wealth Partners LLC	14,900	$40K	0.0%	N/A	0.015%
7/18/2023	Allspring Global Investments Holdings LLC	11,378	$31K	0.0%	-81.0%	0.012%
7/10/2023	SG Americas Securities LLC	10,473	$28K	0.0%	-84.1%	0.011%
5/16/2023	Armistice Capital LLC	2,312,000	$43.14M	0.6%	-40.2%	2.369%
5/16/2023	Baker BROS. Advisors LP	2,637,384	$49.21M	0.3%	+91.8%	2.703%
5/15/2023	Logos Global Management LP	300,000	$5.60M	0.8%	-42.9%	0.307%
5/15/2023	Ghost Tree Capital LLC	26,500	$0.49M	0.1%	N/A	0.027%
5/12/2023	HRT Financial LP	193,099	$3.60M	0.0%	N/A	0.200%
5/12/2023	Martingale Asset Management L P	27,241	$0.51M	0.0%	-28.5%	0.028%
5/12/2023	Profund Advisors LLC	46,366	$0.87M	0.1%	N/A	0.048%
5/11/2023	Artisan Partners Limited Partnership	1,351,230	$25.21M	0.0%	N/A	1.397%
5/10/2023	Vantage Consulting Group Inc	291,707	$5.44M	3.1%	-51.8%	0.302%
5/10/2023	Capula Management Ltd	23,520	$0.44M	0.0%	N/A	0.024%
5/10/2023	Pictet Asset Management SA	1,088,768	$20.32M	0.0%	+120.0%	1.126%
5/10/2023	Swiss National Bank	192,600	$3.59M	0.0%	-10.4%	0.199%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	26,738	$0.50M	0.0%	N/A	0.028%
5/9/2023	BHK Investment Advisors LLC	85,300	$1.59M	0.7%	-2.6%	0.088%
5/9/2023	Integral Health Asset Management LLC	102,000	$1.90M	0.4%	-41.7%	0.105%
5/9/2023	California State Teachers Retirement System	110,952	$2.07M	0.0%	-1.3%	0.115%
5/9/2023	Russell Investments Group Ltd.	138,689	$2.59M	0.0%	-27.1%	0.143%
5/8/2023	Eagle Asset Management Inc.	828,307	$15.46M	0.1%	-8.3%	0.857%
5/8/2023	Federated Hermes Inc.	63,657	$1.19M	0.0%	+203.4%	0.066%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	54,348	$1.01M	0.0%	-41.3%	0.056%
5/8/2023	Sigma Planning Corp	24,935	$0.47M	0.0%	-10.6%	0.026%
5/5/2023	Pinnacle Associates Ltd.	153,134	$2.86M	0.1%	-1.0%	0.158%
5/4/2023	Barclays PLC	170,681	$3.18M	0.0%	-15.7%	0.181%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	67,444	$1.26M	0.0%	+28.0%	0.072%
5/4/2023	Robeco Institutional Asset Management B.V.	13,532	$0.25M	0.0%	N/A	0.014%
5/4/2023	Intercontinental Wealth Advisors LLC	95,650	$1.79M	0.5%	-50.0%	0.102%
5/3/2023	Jump Financial LLC	54,174	$1.01M	0.0%	N/A	0.058%
5/2/2023	Victory Capital Management Inc.	56,980	$1.06M	0.0%	+13.3%	0.061%
5/2/2023	Amalgamated Bank	12,044	$0.23M	0.0%	-11.7%	0.013%
4/28/2023	SG Americas Securities LLC	65,737	$1.23M	0.0%	+98.6%	0.070%
4/27/2023	Arizona State Retirement System	25,863	$0.48M	0.0%	+2.9%	0.027%
4/27/2023	Strs Ohio	42,000	$0.78M	0.0%	-16.8%	0.045%
4/26/2023	State of New Jersey Common Pension Fund D	105,878	$1.98M	0.0%	-36.5%	0.112%
4/20/2023	Institute for Wealth Management LLC.	20,642	$0.39M	0.1%	-21.7%	0.022%
4/18/2023	Assenagon Asset Management S.A.	1,344,583	$25.09M	0.1%	N/A	1.428%
4/14/2023	Raymond James & Associates	52,246	$0.98M	0.0%	-1.4%	0.055%
4/13/2023	Allspring Global Investments Holdings LLC	59,733	$1.12M	0.0%	+480.9%	0.063%
4/6/2023	Baron Financial Group LLC	10,000	$0.19M	0.1%	N/A	0.011%
2/15/2023	Armistice Capital LLC	3,864,000	$61.90M	1.1%	-13.3%	4.112%
2/14/2023	True North Advisors LLC	15,000	$0.24M	0.1%	N/A	0.016%
2/13/2023	ExodusPoint Capital Management LP	110,859	$1.78M	0.0%	N/A	0.118%
2/13/2023	Martingale Asset Management L P	38,075	$0.61M	0.0%	-5.4%	0.041%
2/10/2023	Schroder Investment Management Group	1,760,750	$28.21M	0.0%	+27.7%	1.874%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	52,701	$0.84M	0.0%	+7.7%	0.056%
2/9/2023	First Trust Advisors LP	2,975,653	$47.67M	0.1%	-17.9%	3.167%
2/9/2023	Victory Capital Management Inc.	59,999	$1.04M	0.0%	+36.3%	0.064%
2/9/2023	Principal Financial Group Inc.	24,308	$0.39M	0.0%	+5.3%	0.026%
2/8/2023	Raymond James & Associates	52,977	$0.85M	0.0%	+59.7%	0.056%
2/8/2023	UBS Group AG	195,455	$3.13M	0.0%	+370.3%	0.208%
2/8/2023	Swiss National Bank	215,000	$3.44M	0.0%	+2.3%	0.229%
2/8/2023	Russell Investments Group Ltd.	190,274	$3.05M	0.0%	+78.7%	0.203%
2/8/2023	Arizona State Retirement System	25,129	$0.40M	0.0%	+4.3%	0.027%
2/7/2023	State Board of Administration of Florida Retirement System	29,646	$0.48M	0.0%	-17.2%	0.032%
2/7/2023	Franklin Street Advisors Inc. NC	10,000	$0.16M	0.0%	N/A	0.011%
2/7/2023	TD Asset Management Inc	36,700	$0.59M	0.0%	N/A	0.039%
2/3/2023	U.S. Capital Wealth Advisors LLC	3,393	$54K	0.0%	N/A	0.004%
2/2/2023	SG Americas Securities LLC	33,100	$0.53M	0.0%	-22.2%	0.035%
2/2/2023	Institute for Wealth Management LLC.	26,365	$0.42M	0.1%	-3.6%	0.028%
2/2/2023	ProShare Advisors LLC	19,025	$0.31M	0.0%	+8.5%	0.020%
2/1/2023	State of New Jersey Common Pension Fund D	166,617	$2.67M	0.0%	N/A	0.177%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	92,542	$1.48M	0.0%	+10.7%	0.098%

Data available starting January 2016

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Today's Range

Now: $1.13

$1.13

$1.33

50 Day Range

MA: $1.68

$0.98

$2.64

52 Week Range

Now: $1.13

$0.33

$19.47

Volume

3,878,925 shs

Average Volume

2,713,320 shs

Market Capitalization

$112.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88

Who are the company insiders with the largest holdings of FibroGen?: FibroGen's top insider investors include:
Thane Wettig (CEO)
Enrique A Conterno (CEO)
Christine Chung (SVP)
Mark Eisner (Insider)
Mark Eisner (EVP)
Thane Wettig (Insider)
James A Schoeneck (Director)
Juan Graham (CFO)
Jeffrey William Henderson (Director)
Benjamin Cravatt (Director)
Learn More about top insider investors at FibroGen.
Who are the major institutional investors of FibroGen?: FibroGen's top institutional investors include:
Assenagon Asset Management S.A. — 0.43%
BNP Paribas Financial Markets — 0.14%
Mirae Asset Global Investments Co. Ltd. — 0.06%
Accel Wealth Management — 0.04%
Simplex Trading LLC — 0.00%
SG Americas Securities LLC — 0.03%
Learn More about top institutional investors of FibroGen stock.
Which institutional investors are selling FibroGen stock?: In the previous quarter, FGEN stock was sold by these institutional investors:
Assenagon Asset Management S.A.
BNP Paribas Financial Markets
SG Americas Securities LLC
Within the previous year, company insiders that have sold FibroGen company stock include:
Thane Wettig (CEO)
Enrique A Conterno (CEO)
Christine Chung (SVP)
Mark Eisner (Insider)
Mark Eisner (EVP)
Thane Wettig (Insider)
James A Schoeneck (Director)
Juan Graham (CFO)
Learn More investors selling FibroGen stock.
Which institutional investors are buying FibroGen stock?: During the last quarter, FGEN stock was acquired by institutional investors including:
Mirae Asset Global Investments Co. Ltd.
Accel Wealth Management
Simplex Trading LLC